NASA Maneuvers For A Linkup With NIH

With its traditional bent toward physical sciences, the National Aeronautics and Space Administration has never funded biological studies adequately, and biological investigators have not taken space science seriously, space agency officials say. So, to boost biology into a high-profile orbit within the space program while delivering payoffs to National Institutes of Health-funded investigators on the ground, NASA administrator Daniel Goldin and NIH director Bernadine Healy recently signed an a

Written byTom Abate
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The agreement makes it possible for NIH-funded biologists to get experiments into orbit and to tap into NASA expertise. And, for the first time, outside investigators will have access to NASA ground facilities for their own research. In return, the agreement set up a mechanism for space agency scientists to suggest research projects that would be funded through NIH grants.

NIH officials are vague about how much money would be set aside for research with a space component, which biologist Richard Sprott, associate director of the National Institute on Aging, describes as "experiments of mutual interest" to NASA and NIH. "Frankly, we want to test the waters," Sprott says, adding that grant levels would depend on the number and quality of applications that come in as biologists become aware of the possibilities of space-oriented research and begin suggesting projects.

Since August 28, space scientists of all stripes have converged on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies